Search Results

search

Search Filters

Tag
Pharma
XXXX.png
Silexion Therapeutics Announces 1-for-9 Reverse Share Split
November 22, 2024 16:30 ET | Silexion Therapeutics Corp
GRAND CAYMAN, Cayman Islands, November 22, 2024 – Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion” or the “Company”), a clinical-stage biotech developing RNA interference (RNAi) therapies for...
XXXX.png
Silexion Therapeutics to Present at the Noble Capital Markets 20th Annual Emerging Growth Equity Conference
November 20, 2024 08:30 ET | Silexion Therapeutics Corp
GRAND CAYMAN, CAYMAN ISLANDS, Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion” or the “Company”), a clinical-stage biotech developing RNA interference (RNAi) therapies for KRAS-driven cancers,...
P1645378
KFSHRC Introduces Pioneering Virtual Pathology Services in Madinah
November 17, 2024 10:49 ET | King Faisal Specialist Hospital & Research Centre
KFSHRC Introduces Pioneering Virtual Pathology Services in Madinah
KFSH&RC Robotic Cardiac Surgery
KFSHRC to Host Minimally Invasive Organ Transplant Consensus Conference in Riyadh
November 13, 2024 08:45 ET | King Faisal Specialist Hospital & Research Centre
KFSHRC to Host Minimally Invasive Organ Transplant Consensus Conference in Riyadh
Hyku_Bio_ID_Primary_High.png
Hyku Biosciences Appoints John Gustofson to its Board of Directors
November 12, 2024 07:45 ET | Hyku Biosciences
John Gustofson, MS, MBA appointed to the Board of Directors The appointment is in conjunction with Chugai Venture Fund joining syndicate with an investment that brings Hyku’s total seed financing to...
Nodenza Logo.png
Nodenza Venture Partners appoints George Freeman as Chair of Advisory Board
November 12, 2024 07:00 ET | Nodenza Venture Partners
Nodenza Venture Partners appoints George Freeman as Chair of Advisory Board New York, November 12, 2024 – Nodenza Ventures Partners (“Nodenza”), today announces the appointment of George Freeman, MP,...
Logo_AdipoPharma_V1.png
French Biotech Company AdipoPharma Secures Funding to Initiate Clinical Trials for its first-in-class compound for Insulin Resistance
November 11, 2024 12:43 ET | AdipoPharma
STRASBOURG, France, Nov. 11, 2024 (GLOBE NEWSWIRE) -- AdipoPharma, a biotech company headquartered in France with offices in the US and Belgium developing a novel and promising Type 2 diabetes drug,...
E'20-228_MAD_1952
KFSHRC’s New US Patent Opens New Frontiers for Breast Cancer Treatment
November 10, 2024 07:26 ET | King Faisal Specialist Hospital & Research Centre
KFSHRC’s New US Patent Opens New Frontiers for Breast Cancer Treatment
Logo-OLON+payoff.jpg
Olon ist bereit für die Produktion in der neuen Anlage für hoch starke Wirkstoffe
November 04, 2024 05:00 ET | Olon SpA
MAILAND, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Olon, ein Arzneimittelhersteller und globales CDMO-Unternehmen, bestätigt den Zeitplan für den Bau seiner neuen Produktionsanlage für hoch starke...
Logo-OLON+payoff.jpg
Olon is ready to host productions in the new facility dedicated to ultra-potent compounds
November 04, 2024 05:00 ET | Olon SpA
Olon is ready to host productions in the new facility dedicated to ultra-potent compounds